Home
>
National Drug Code (NDC)
>
ABREVA
ABREVA - 0135-0200-04 - (docosanol)
Drug Information of ABREVA
| Product NDC: | 0135-0200 |
| Proprietary Name: | ABREVA |
| Non Proprietary Name: | docosanol |
| Active Ingredient(s): | 100 mg/g & nbsp; docosanol |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ABREVA
| Product NDC: | 0135-0200 |
| Labeler Name: | GlaxoSmithKline Consumer Healthcare LP |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | NDA020941 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100319 |
Package Information of ABREVA
| Package NDC: | 0135-0200-04 |
| Package Description: | 2 TUBE in 1 PACKAGE (0135-0200-04) > 2 g in 1 TUBE |
NDC Information of ABREVA
| NDC Code | 0135-0200-04 |
| Proprietary Name | ABREVA |
| Package Description | 2 TUBE in 1 PACKAGE (0135-0200-04) > 2 g in 1 TUBE |
| Product NDC | 0135-0200 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | docosanol |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20100319 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline Consumer Healthcare LP |
| Substance Name | DOCOSANOL |
| Strength Number | 100 |
| Strength Unit | mg/g |
| Pharmaceutical Classes |
